Bio-Rad Laboratories (BIO) EBIAT (2016 - 2025)
Historic EBIAT for Bio-Rad Laboratories (BIO) over the last 17 years, with Q4 2025 value amounting to $720.0 million.
- Bio-Rad Laboratories' EBIAT rose 20058.68% to $720.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $759.9 million, marking a year-over-year increase of 14120.49%. This contributed to the annual value of $759.9 million for FY2025, which is 14120.49% up from last year.
- Bio-Rad Laboratories' EBIAT amounted to $720.0 million in Q4 2025, which was up 20058.68% from -$341.9 million recorded in Q3 2025.
- Over the past 5 years, Bio-Rad Laboratories' EBIAT peaked at $3.9 billion during Q3 2021, and registered a low of -$3.4 billion during Q1 2022.
- Its 5-year average for EBIAT is -$54.7 million, with a median of $87.6 million in 2023.
- In the last 5 years, Bio-Rad Laboratories' EBIAT plummeted by 44360.2% in 2022 and then skyrocketed by 51448.73% in 2024.
- Over the past 5 years, Bio-Rad Laboratories' EBIAT (Quarter) stood at -$1.6 billion in 2021, then soared by 152.65% to $827.7 million in 2022, then crashed by 57.75% to $349.7 million in 2023, then plummeted by 304.69% to -$715.8 million in 2024, then surged by 200.59% to $720.0 million in 2025.
- Its EBIAT stands at $720.0 million for Q4 2025, versus -$341.9 million for Q3 2025 and $317.8 million for Q2 2025.